Featured Research

from universities, journals, and other organizations

Counterfeit contraceptives found in South America

Date:
April 18, 2014
Source:
Georgia Institute of Technology
Summary:
A survey of emergency contraceptive pills in Peru found that 28 percent of the batches studied were either of substandard quality or falsified. Many pills released the active ingredient too slowly. Others had the wrong active ingredient. One batch had no active ingredient at all.

Facundo M. Fernández, a professor in the School of Chemistry and Biochemistry, examines an emergency contraceptive pill with ambient mass spectrometry.
Credit: Rob Felt

A survey of emergency contraceptive pills in Peru found that 28 percent of the batches studied were either of substandard quality or falsified. Many pills released the active ingredient too slowly. Others had the wrong active ingredient. One batch had no active ingredient at all.

To detect the fake drugs, researchers at the Georgia Institute of Technology developed a sophisticated approach using mass spectrometry to quickly assess suspected counterfeit drugs and then characterize their chemical composition. The study's results highlight a growing concern for women's health in developing nations.

"A woman who does not want to get pregnant and takes these emergency contraceptives will get pregnant," said Facundo M. Fernández, a professor in the School of Chemistry and Biochemistry, whose lab investigated the contraceptives.

The study was sponsored by the ACT Consortium through a grant from the Bill and Melinda Gates Foundation. The study was published April 18 in the journal PLOS ONE.

Drugs are considered fake or falsified when someone makes a pirate copy of copies a patented drug, with criminal intent. Recent research has found that falsified drugs are a major problem in developing countries. Falsified emergency contraceptives have been reported in Nigeria, Ghana, Kenya, Angola, South America and even the United States. Fake drug manufacturers will copy everything from the pill to the package.

Just as concerning as counterfeit medications are other poor quality medications, such as degraded or substandard drugs. Degraded drugs were once good quality, but lost their efficacy over time, for example after prolonged exposure to the sun in an open air market. Substandard drugs are made by an approved factory, but they don't contain the right active ingredient, contain less active ingredient than they should, or might not dissolve properly. These pills either result from factory error or negligence.

Falsified drugs are the most worrisome, because they may not contain the expected active ingredient, or they may contain the wrong ingredients, including toxic compounds.

In the survey of emergency contraceptives from Peru, the researchers found that seven of the 25 batches analyzed had inadequate release of the active ingredient (levonorgestrel). One batch had no detectable level of the active ingredient.

"We detected that the active ingredient was not there in one batch, instead those samples had a drug called sulfamethoxazole," Fernandez said. "It's a very common antibiotic. It can cause serious adverse reactions in some patients."

For the study, samples of emergency contraceptives were purchased at 15 pharmacies and distributors in Lima, Peru, with 60 tables purchased per sample. Tablets were collected from 25 different product batches encompassing 20 brands labeled as manufactured in nine countries (Argentina, Chile, China, Colombia, Hungary, India, Pakistan, Peru and Uruguay).

Analyzing these samples is time consuming and costly with standard tools, so Fernandez's lab developed a method for a quick screen to identify problematic pills. The first-pass screen then allows the researchers to focus a sophisticated analysis on drugs that are suspected fakes. The drugs that pass the screen will still be closely analyzed, but after the suspected fakes.

Fernandez's lab used a tool called ambient mass spectrometry. Scientists in the lab grasp a tablet with a pair of tweezers and swing it front of the instrument to get a real-time signature of the tablet's chemical composition.

"Very quickly we pick out which ones are the problems," Fernandez said.

Their analysis is a tiered-approach. First they look for the presence and identity of the active ingredient. Then they look to see if the right amount is present. Then they test if the pill properly dissolves. Many sophisticated fake pills might pass all these tests, so the scientists also look at the filler in the pills, known as the excipients, such as lactose and cellulose.

"Many fakes are very sophisticated. They have the right active ingredient and they may even have the right amount, but the excipients or coatings may not be the right ones," Fernandez said.

His students have processed thousands of samples and can spot many fake pills before performing the analysis.

"They touch it a bit with their nails and they try to cut into it and they know it's like a rock, just way too hard," Fernandez said. "The tablets are sometimes so hard that they won't dissolve. That's something that you pick up pretty quickly."

Fernandez's lab is working to make these mass spectrometry tools portable so that researchers might be able to do these analyses in the field.

"You really want to catch these fakes early, at the customs level or at the distribution center level," Fernandez said. "You don't want to wait for this to get to the pharmacy or for somebody to report it."

This research is supported by the Bill and Melinda Gates Foundation.


Story Source:

The above story is based on materials provided by Georgia Institute of Technology. The original article was written by Brett Israel. Note: Materials may be edited for content and length.


Journal Reference:

  1. María Eugenia Monge, Prabha Dwivedi, Manshui Zhou, Michael Payne, Chris Harris, Blaine House, Yvonne Juggins, Peter Cizmarik, Paul N. Newton, Facundo M. Fernández, David Jenkins. A Tiered Analytical Approach for Investigating Poor Quality Emergency Contraceptives. PLoS ONE, 2014; 9 (4): e95353 DOI: 10.1371/journal.pone.0095353

Cite This Page:

Georgia Institute of Technology. "Counterfeit contraceptives found in South America." ScienceDaily. ScienceDaily, 18 April 2014. <www.sciencedaily.com/releases/2014/04/140418190203.htm>.
Georgia Institute of Technology. (2014, April 18). Counterfeit contraceptives found in South America. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2014/04/140418190203.htm
Georgia Institute of Technology. "Counterfeit contraceptives found in South America." ScienceDaily. www.sciencedaily.com/releases/2014/04/140418190203.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) — Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) — The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) — Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) — New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins